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In this study, we present a comprehensive approach to the design and development of magnetosomes 
with antibodies immobilized on their surface by integration in membrane in vitro. Designed fusion proteins 
Mbb and Mistbb consisted of anchor proteins and BB-domains of Staphylococcus aureus protein A as IgG-
binding region were used for development of IgG-binding magnetosomes. The magnetosome membrane 
protein MamC and membrane protein of Bacillus subtilis Mistic were selected as anchor proteins. Using 
Response Surface Methodology (RSM), the high level of fusion proteins integration into bacterial nanopar-
ticles membrane was achieved. IgG-binding magnetosomes obtained through this strategy could serve as 
multifunctional platform for displaying various types of antibodies. Such systems could be applied as 
theranostic agents.   
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1. INTRODUCTION 
 
The systems consisting of antibodies conjugated to 
the surface of magnetic nanoparticles (MNPs) are being 
increasingly used in the diagnostics and therapy. Their 
efficiency for the detection of cancer cells, the magnetic 
separation of stem cells, magnetic immunoassay and as 
a carrier for targeted delivery of drugs have been previ-
ously demonstrated in the numerous studies [1]. De-
spite the fact that artificial MNPs are commonly used 
in these applications, chemically synthesized magnetic 
crystals have several disadvantages, e.g. size and shape 
heterogeneity [2]. In recent years the magnetosomes 
were proposed as an alternative to synthetic MNPs. 
Magnetosomes are intracellular magnetic crystals pro-
duced by magnetotactic bacteria and also referred to as 
bacterial magnetic nanoparticles (BMPs) (Fig. 1).  
 
  
 
Fig. 1 –Magnetospirillum sp. SO-1 (a), magnetosome chain (b) 
 
The advantages of magnetosomes in comparison 
with artificial MNPs are: i) uniform species-specific size 
(45-60 nm) and shape; ii) crystal is coated with a lipo-
protein membrane, that makes BMPs easily dispersed 
in aqueous suspension and provides an opportunity to 
modify a surface by methods of genetic engineering; iii) 
low cytotoxicity [3]. 
In this study, we present a comprehensive approach 
to the design and development of BMPs with antibodies 
immobilized on their surface by integration in mem-
brane in vitro. For this purpose, we designed the fusion 
proteins Mbb and Mistbb consisted of anchor protein 
and BB-domains of Staphylococcus aureus protein A as 
IgG-binding region. MamC and Mistic were selected as 
anchor proteins. 
 
2. MATERIALS AND METHODS 
 
2.1 Cultivation of Magnetotactic Bacteria 
 
The medium for Magnetospirillum sp. SO-1 consist-
ed of (per liter of medium): 1 ml mineral solution, 0.7 g 
KH2PO4, 0.5 g sodium succinate, 0.1 g yeast extract, 
0.35 g NaNO3, 10 ml 0.01 M ferric citrate, 0.05 g sodi-
um thioglycolate. The pH was adjusted to 6.75 with 
NaOH. The cells were cultivated at 28 °C under micro-
aerobic conditions in 15l fermentor for 3-4 days. 
 
2.2 Magnetosomes Isolation and Purification 
 
The stationary phase cells were centrifuged at 
10000g for 10 min at 4 °C, resuspended in 20 mM 
HEPES buffer, pH  7.4, contained 4 mM EDTA and 0.1 
mM phenylmethylsulfonyl fluoride (PMSF) and disrupt-
ed by sonication (Sonopuls, Bandelin). Magnetosomes 
were magnetically isolated from disrupted cell fractions 
using a neodymium-boron (Nd-B) magnet and washed 
15 times with 20 mM HEPES buffer, pH  7.4. The 
washed magnetosomes were suspended in the same 
buffer and stored at + 4° C. 
2.3 Expression and Purification of Fusion Pro-
teins Mbb and Mistbb 
 
Expression, purification and IgG-binding activity 
assays of fusion protein Mbb were reported previously 
[4]. Gene mistic was obtained by PCR from genomic 
DNA of Bacillus subtilis (NdeI-MisF  
5’-AGAGGAGATATCATATGGGCTTT-3’ and BamHI-
MisR 5’-CAGAACCGGATCCTTCTTTTTCTC-3’). NdeI 
and BamH1 digested mistic PCR product was cloned 
into vector pET23a(+)/mbb where it substituted mamC 
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in genetic construct mbb. XL1 Blue E. coli cells were 
transformed by the pET23a(+)/mistbb recombinant 
plasmids and other steps of Mistbb expression and pu-
rification were carried out as for Mbb. 
 
2.4 Optimization of Fusion Proteins Insertion 
into Magnetosome Membrane 
 
The optimization of Mbb and Mistbb insertion into 
magnetosome membrane was carried out according to 
Response Surface Methodology (RSM). The following 
factors that have a significant impact on the integra-
tion of fusion proteins in the magnetosome membrane 
have been selected after series of pilot experiments: pH, 
NaCl, together with the influence of mechanical impact 
mode on suspension (vortexing or sonication). The re-
spective levels with the encoded levels for the factors 
are listed in Table 1.  The resulted calculated data were 
obtained using Minitab 15.0. 10 µg of magnetosomes 
and 50 µg of each fusion protein were used in each op-
timization experiments. The volume of reaction mix-
ture was 1 ml. 
 
Table 1 – The level of variables for BBD 
 
 
 
2.5 Atomic Force Microscopy 
 
Experiments were performed on NTEGRA Prima 
microscope (NT-MDT, Russia). AFM was used for visu-
alization, size measurements and magnetic force meas-
urements of biogenic magnetic nanoparticles. Semicon-
tact scanning mode was used in experiments. 10 l of 
solutions was incubated on freshly cleaved mica for 1 
min before rinsing thoroughly with milliQ water and 
drying in a dry air stream. Samples were scanned im-
mediately after drying at room temperature and ambi-
ent humidity with no special treatment. 
 
2.6 MALDI-TOF Analysis of Membrane 
 
MALDI-TOF-MS (Bruker REFLEX III, Germany) 
equipped with a 337-nm nitrogen laser was used to 
analyze the molecular weights of proteins. Alpha-
cyano-hydroxycinnamic acid (CHCA) was used as ma-
trix. Samples were extracted, applied onto the target 
and allowed to air dry. Subsequently, 0.5 μL of CHCA 
in acetonitrile (ACN)/0.1 % trifluoroacetic acid (TFA) 
(1:2, v/v) solution was applied to the dried sample and 
again allowed to dry. MALDI-TOF-MS spectra were 
acquired in positive-ion, with acceleration potential of 
20 kV and linear modes with external calibration. The 
spectra were calibrated using the protein Standard I 
(5.000 to 20.0000 kDa range) and II (20.000 to 
70.0000 kDa range) from Bruker-Daltonics.. 
 
2.7 ELISA 
 
IgG-binding activity of Mbb and Mistbb was com-
pared by ELISA. Human insulin (1 mg) was pread-
sorbed in the wells of an ELISA plate overnight at 
+4 °С. The residual sorption was blocked by a 1.5% 
solution of BSA in a PBS-Tween buffer (PBS, 0.05% 
Tween 20) for 1 h. Monoclonal mouse antibodies (0.1 
μg) against human insulin (Imtek, Russia) were added 
to the wells and incubated for 1 h at room temperature. 
The wells were washed four times with PBS-Tween 
buffer, and then the fusion proteins were added at the 
specified dilution and incubated for 1 h. After a similar 
washing procedure, the plates were incubated with 0.1 
μg of mouse antibodies against the histidine tag 
(Imtek, Russia) for 1 h and detection was performed 
using a hydrogen peroxide/horseradish peroxidase de-
tection system with TMB (Sigma, United States) as a 
chromogenic substrate. A polypeptide carrying a histi-
dine tag at the C-terminus was used as a negative con-
trol. 
 
2.8 Magnetic ELISA 
 
IgG-binding activity of modified magnetosomes was 
tested by ELISA. 10 µg of modified magnetosome was 
incubated for 1 h at room temperature with 100 µl of 
rabbit antibodies (100 µg/ml) labeled with horseradish 
peroxidase (Imtek, Russia). After that magnetosomes 
were separated on magnetic stand (Promega, USA) and 
washed 5 times with 100 µl PBS-Tween buffer to wash 
out from unbound antibodies. After washing, magneto-
somes were incubated with a chromogenic substrate 
TMB for 1 min, the reaction was terminated 50 µl 1 M 
HCl. When checking the optimal parameters predicted 
by the mathematical model.  
 
3. RESULTS AND DISCUSSION 
 
Below we demonstrate the application of Mistic as 
anchor protein for integration into magnetosome mem-
brane. Being the fusion proteins expressed and purified, 
the IgG-binding activity of Mistbb and Mbb was com-
pared. As it was shown by ELISA, Mistbb and Mbb ex-
hibited the similar IgG-binding activities. Thus both 
proteins were selected for further experiments. 
The factors influencing the process of fusion proteins 
integration have been identified in the series of pilot 
experiments: pH, NaCl concentration and method of 
mechanical impact. Protein composition of modified and 
intact magnetosome membrane was performed by 
MALDI-TOF-MS to detect the insertion of fusion pro-
teins in magnetosome membrane (Fig. 2). 
 
  
Fig. 2 - Proteomic profile magnetosome membrane before 
modification (a), after modification (b) 
  
Response Surface Methodology (RSM) was used for 
optimization of fusion proteins integration into magneto-
some membrane. This methodology is an effective tool 
for prediction of optimal process condition for a multivar-
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iable systems [5]. Box-Behnken design (BBD) was used 
to determine the optimum levels of the three variables 
selected for each fusion protein. To determine the level of 
Mbb and Mistbb IgG-binding activity exhibiting after 
insertion into magnetosome membrane the magnetic 
ELISA was performed. Experimental design and mag-
netic ELISA results are compared in Table 2. 
 
Table 2 - BBD along with OD450 (ELISA) production as 
response 
 
A B C Sonication Vortex Sonication Vortex
1 0 -1 -1 0,598 0,236 0,708 0,994
2 1 -1 0 0,184 0,861 0,319 0,129
3 0 -1 1 1,258 1,058 1,132 0,779
4 -1 0 1 0,465 0,465 0,258 0,232
5 0 0 0 0,681 0,652 0,441 0,297
6 0 0 0 0,469 0,674 0,548 0,134
7 -1 0 -1 0,652 0,469 0,841 1,066
8 -1 -1 0 0,442 0,168 0,258 0,634
9 0 0 0 0,931 0,64 0,473 0,155
10 1 0 1 0,352 0,598 0,265 0,793
11 0 1 1 0,861 0,352 0,347 0,14
12 1 1 0 0,974 0,442 0,206 0,808
13 -1 1 0 0,636 0,931 0,493 0,471
14 1 0 -1 0,84 0,184 0,203 0,817
15 0 1 -1 0,168 0,681 0,982 0,265
Run
Variable Level Mbb ELISA OD450 Mistbb ELISA OD450
 
 
The highest OD450 values were obtained when inte-
gration was performed under parameters predicted by 
the RSM (Fig. 3).  
 
 
 
Fig. 3 - Magnetic immunoassay results 
 
The morphology and size of modified magnetosome 
was analyzed by atomic force microscopy. The size of 
intact magnetosome was 50-60 nm, and the size of 
antibody was about 25 nm (Fig. 4a-b).  
After integration of hybrid proteins in the 
membrane followed by magnetosome incubation with 
antibodies, an increase of particle size to 85-95 nm was 
detected, thus indicating on the antibody binding by 
fusion proteins immobilized on the surface of bacterial 
nanoparticles. It should be noted that unmodified 
magnetosome resized and their morphology did not 
occur after incubation with the antibodies. This 
conclusion is based on the fact of the absence of non-
specific adsorption of antibodies. 
 
 
 
Fig. 4 – AFM data for bacterial magnetic nanoparticles before 
modification (a), polyclonal rabbit IgG (b), magnetosomes after 
insertion of IgG-binding fusion protein Mbb (c), after insertion 
of IgG-binding fusion protein Mistbb (d), unmodified magneto-
somes incubated with antibodies (e) 
 
4. CONCLUSIONS 
 
In this study the optimized method for design of IgG-
binding magnetosomes by insertion of fusion protein 
with IgG-binding activity into magnetosome membrane 
was proposed. One of the benefits of magnetosomes is 
that their native membrane could perform a platform for 
the protein display. Another essential advantage is flexi-
bility or universality of IgG-binding magnetosomes, since 
modified BMPs could be labeled with different antibodies 
depending on diagnostic purposes.  
It was shown that not only magnetosome membrane 
proteins but also Mistic can be effectively used as an 
anchor molecule for integration into BMPs membrane.  
IgG-binding magnetosomes are applicable for various 
diagnostics in vitro. Moreover modified magnetosomes 
could be used for in vivo applications, e.g. imaging of 
tumors by MRI. BMPs modified with fluorescent labeled 
antibodies will expand the possibilities of visualization of 
biological samples. It was reported previously that mag-
netosomes are extremely effective in hyperthermal tu-
mor therapy. Thus IgG-binding BMPs has a great poten-
tial as “theranostic” agent. 
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